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Abstract Human neuroblastoma cells (IMR32) respond to
treatment with either dibutyryl-cAMP or nerve factor by
acquiring a neuronal phenotype which is accompanied by a
marked increase in the density of neuronal (N-type) VDCC
currents. Using IMR32 cells as a model for neuronal differentia-
tion, we were interested in examining possible changes in the level
of expression of the K1B subunit of N-type calcium channels as
well as beta subunit isoforms. Upon differentiation with
dibutyryl-cAMP and 5-bromo-2-deoxyuridine for 16 days, we
observed a dramatic increase in K1B protein which initiated
between day 8 and 10. Day 10 evidenced maximal expression of
K1B protein, which was followed by an interval of relatively
constant expression of K1B (day 12 to day 16). Monitoring beta
subunit expression using a pan specific anti-beta antibody (Ab
CW20), we observed an increase in expression of a single 82 kDa
beta subunit. The predominant 82 kDa beta subunit expressed
throughout the course of differentiation was identified as the L1b
isoform using a panel of beta subunit specific antibodies. Of
significance, neither the L2 nor L3 isoforms were detected in full
differentiated IMR32 cells. Contrary to a previous report on the
absence of neurotypic expression of VDCC beta subunits in a
second model for in vitro differentiation, NGF-treated rat
pheochromocytoma cells (PC12 cells) [1], we report the regulated
expression of the L1b protein in differentiated IMR32 cells
suggesting a cell specific function for this beta subunit which
parallels the acquisition of the neuronal phenotype. The
restrictive expression of the L1b in IMR32 cells may reflect a
cell-type specific function that extends beyond its role as an
auxiliary subunit of VDCC complexes.
z 1997 Federation of European Biochemical Societies.
Key words: Calcium channel; Beta subunit ; Di¡erentiation;
Neuronal phenotype; Neuroblastoma
1. Introduction
The process of neurodi¡erentiation involves changes in cell
morphology, the extension of neurites, and the establishment
of synaptic connections requiring the acquisition of proper
cellular ‘machinery’, including secretory apparatus, receptors
and ion channels. While the immature central and peripheral
nervous systems provide authentic starting points from which
to investigate this process, the complexity of molecular events
and the array of di¡erent signaling processes make it ex-
tremely di⁄cult to study speci¢c factors that in£uence di¡er-
entiation. Therefore, several cell lines have been developed to
model neurodi¡erentiation and include rat pheochromocyto-
ma cells (PC12) and human neuroblastoma cells (IMR32) [2].
Both of these cell lines in the presence of nerve growth factor
(NGF) and other agents are induced to obtain a sympathetic
neuronal phenotype [3]. It is known that the di¡erentiation of
excitable cells is accompanied by changes in electrical proper-
ties, including the increased expression of potassium [4], so-
dium and calcium channels [5,6]. PC12 cells exhibit both di-
hydropyridine (DHP)-sensitive L-type, 9-conotoxin-sensitive
N-type channels [7] and have been recently shown to also
express an 9-agatoxin-IVA-sensitive (P/Q) type component
[1]. The preferential localization of DHP-sensitive L-type
channels to the cell soma, with N-type channels present in
growth cones from these cells hinted at a possible role of
the N-type channel in neurite development [8]. An early role
of calcium current in the regulation of soma and neurite out-
growth, rather than solely as a trigger for neurotransmitter
release has been suggested by earlier experiments [9].
A similar pattern of expression and localization of the
N-type VDCC has been observed in rat brain wherein
N-type channels were detected along nerve processes and
nerve terminals by immunohistochemical localization [10]. Im-
munochemical and biochemical characterization of the N-type
calcium channel complex from brain shows it to consist of at
least three subunits (K1, L, K2/N) [11^14]. To date at least four
di¡erent beta subunit genes (L1, L2, L3, L4) have been cloned
[15^19]. The apparent molecular weights of the translated beta
subunit cDNAs fall into ‘high’ molecular weight beta subunits
(L1 and L2, with anticipated apparent molecular weights of
approximately 66 kDa and 69 kDa, respectively) and ‘low’
molecular weight beta subunits (L3 and L4, with apparent
molecular weights of approximately 55 kDa and 58 kDa, re-
spectively) [15^19]. Reports that investigated the subunit com-
position of N-type [12] and L-type VDCC [20] in brain ho-
mogenates have concluded that the beta subunits do not
preferentially assemble with speci¢c subunits. Moreover, de-
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spite the intense interest in determining the structural features
which contribute to the formation of the speci¢c K1, K2/N and
L subunit complexes, the underlying tra⁄cking and sorting
mechanisms remain elusive [12,21]. In a more simpli¢ed sys-
tem such as rat PC12 cells, the N-type calcium channel is
predominantly associated with the L2 and L3 subunits [1].
However, it was di⁄cult to determine if this association sim-
ply re£ects the relative abundance of these beta isoforms in
PC12 cells rather than a speci¢c K1B-beta subunit enrichment.
Interestingly, despite increases in the level of K1B subunit
(9-conotoxin binding subunit of the N-type VDCC) ex-
pressed upon NGF-induced di¡erentiation, there was no
change in the relative contribution of either L2 or L3 subunit
to the immunoprecipitated N-type VDCC complex [1].
There is very little known concerning N-type calcium chan-
nel beta subunit composition or the role it might play in
IMR32 cell di¡erentiation. In di¡erentiating IMR32 cells,
the transient appearance of a low voltage-activated calcium
channel is followed by a marked increase in the appearance of
N-type calcium channels as measured electrophysiologically
and monitored by [125I]CTX binding [22]. The purpose of
this study is to examine the expression of the K1B subunit
as well as the resident beta subunits which are present in
IMR32 cells with an eye towards determining the subunit
structure of the endogenous N-type VDCC complex. Here
we report that cAMP-induced IMR32 cells show a speci¢c
increase in L1b subunit expression which parallels the increase
in N-type calcium channel expression during neurodi¡erentia-
tion.
2. Materials and methods
Aprotinin, pepstatin, calpain inhibitors I and II, and choline chlo-
ride were obtained from Calbiochem. Enhanced chemiluminescence
kit (ECL) was purchased from Amersham, unlabeled omega GVIA
conotoxin from Peninsula Laboratories, [125I]Tyr-22-9-conotoxin
GVIA from New England Nuclear. Nitrocellulose membranes
(0.45 um) were obtained from S and S. All secondary antibodies
were from Boehringer Mannheim. Bovine serum albumin was from
United States Biochemicals, Inc. HEPES was from Research Organ-
ics. BCA protein assay reagents and Sulfolink columns were obtained
from Pierce, dialysis tubing (12^14 kDa cut-o¡) was obtained from
Fisher. All other reagents were obtained from Sigma Chemicals.
2.1. Production of anti-peptide antibodies to VDCC K1B and L subunits
Anti-K1B subunit antibodies (Ab CW14) were raised to amino acid
residues 1051^1069 in the rat K1B [23] which were present in all N-
type K1 subunit cDNAs cloned to date [24^26]. Anti-beta subunit
‘generic’ antibodies (Ab CW20) were raised to a highly conserved
sequence (ESYTSRPSDSDVSLEEDRE) present in all beta subunits
cloned to date. The anti-L4 antibody was raised to a 16 amino acid
peptide (ENYHNERKSRNRLS) speci¢c to the L4 subunit [27]. These
peptide antigens were synthesized to include a unique cysteine residue
to be used both in the unambiguous attachment of peptide to carrier
protein (maleimide-derivatized KLH) and to the a⁄nity column (Sul-
folink). The peptides were puri¢ed, and coupled to maleimide-acti-
vated KLH and used in the production of polyclonal sera in rabbits
bled twice per month (15^20 ml/bleed) and tested after four weeks.
2.2. Preparation of peptide columns immobilized via CYS residue and
a⁄nity puri¢cation of anti-K1B (CW14), anti-L4 and anti-L
generic (Ab CW20) antibodies
The free, reduced peptides (1.5 to 3 mg in 2 ml volume) were
coupled to a Sulfolink column (Pierce) according to the manufactur-
er’s instructions. The coupling e⁄ciency was 94^99% as determined by
dot blotting and Ellman’s assay. Antibodies were a⁄nity puri¢ed by
diluting crude antisera with 3% BSA in 1UTBS and incubating with
peptide column for 90 min at room temperature. The column was
then washed sequentially with TBS, 30 mM glycine pH 5, and
80 mM glycine pH 4. The a⁄nity puri¢ed antibodies were eluted
from the column with 200 mM glycine pH 2.5 and immediately neu-
tralized by the addition of 1 M Tris pH 12.0. The antibody fractions
were pooled and dialyzed overnight against TBS plus 1 mM EGTA.
The antibodies were dialyzed against an additional volume of TBS,
aliquoted and stored at 380‡C. A⁄nity puri¢ed Ab CW20 reacted
with all recombinant beta subunit isoforms expressed in HEK293 cells
(data not shown) and a⁄nity puri¢ed Ab CW14 reacted with the
230 kDa K1B subunit present in human, rat, rabbit and mouse sam-
ples (data not shown). The anti-L1b, anti-L2, and anti-L3 isoform
speci¢c antibodies used in this study have been characterized else-
where [20,28].
2.3. Di¡erentiation of human neuroblastoma cells (IMR32 cells)
IMR32 human neuroblastoma cell line was obtained from the
ATCC and grown in Eagle’s minimal essential medium supplemented
with 100 units of penicillin per ml and 100 ug of streptomycin and
10% fetal bovine serum. Cells were plated at a density of 104/cm2 in
plastic dishes or £asks and cultured at 37‡C in a 5% CO2 humidi¢ed
atmosphere. Di¡erentiation of IMR32 cells was carried out by treat-
ing IMR32 cells with a mixture of 1 mM dibutyryl-cAMP and 2.5 uM
5-BdUR for a period of 16 days as described [29]. Cells were har-
vested into PBS plus copious protease inhibitors prepared as follows:
PMSF (1/1000 dilution from 200 mM stock in ethanol), calpain in-
hibitors I and II (1/1000 dilution from 4 mg/ml stock), benzamidine
(1/500 dilution of 200 mM stock), aprotinin (1/500 dilution from 1 mg/
ml stock), leupeptin (1/500 dilution from 1 mg/ml stock), pepstatin (1/
500 dilution from 1 mg/ml stock). The IMR32 cell di¡erentiation and
parallel Western blot analyses were carried out in three independent
experiments on cells of di¡erent passage number with similar results.
2.4. Preparation of tissue homogenates and membranes
Adult rats were killed by euthanasia and the forebrains and other
organs removed and immediately placed in 50 mM HEPES pH 7.4,
1 mM EGTA plus protease inhibitors as described [11]. For subse-
quent use in Western blot analysis, all samples were stored in 320‡C
at concentrations of 2 mg/ml in sample bu¡er (5Usample bu¡er:
325 mM Tris pH 7.0, glycerol (25% v/v), mercaptoethanol (25% v/
v), SDS (10%) in 100 ul aliquots. The samples were frozen once, used
and then discarded.
2.5. Methods for [125I]CTX binding
[125I]CTX ([125I-Tyr-22]-9-conotoxin) GVIA (speci¢c activity 2000
Ci (81.4 TBq)/mmol) binding was assayed by published procedures
[30] which use ¢ltration over PEI-soaked glass ¢ber ¢lters (Whatman
GF/B) to separate bound from unbound ligand in the presence of
bovine serum albumin (BSA). Unlabeled CTX added was from
0.1 pM to 50 nM in the presence of constant [125I]CTX (4.2^5 pM).
The values reported in the text represent the average of more than ¢ve
independent determinations done in duplicate þ S.E.M.
2.6. Western blot analysis and general methods
Gels were transferred to nitrocellulose at 0.45 A for 17 to 22 h, the
¢lters blocked in 5% powdered milk in 1UTBS+0.01% sodium
azide+0.05% Tween. The primary antibody was diluted in 3% BSA
and 1UTBS and incubated with the ¢lter overnight at 4‡C. Various
preparation of a⁄nity puri¢ed anti-K1B and anti-L antibodies were
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Fig. 1. Identi¢cation of rat brain L subunits by generic anti-beta
antibody and beta isoform speci¢c antibodies. Rat forebrain (75 Wg/
lane) was resolved on a 4^17% gradient gel, transferred to nitrocel-
lulose and probed with Ab CW20 (lane 1) and isoform speci¢c anti-
bodies to the L1b (lane 2), L2 (lane 3), L3 (lane 4) and L4 (lane 5).
The position of the subunits was detected with goat anti-rabbit sec-
ondary antibodies conjugated to HRP and visualized by ECL as de-
scribed in Section 2.
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used throughout the course of these experiments with identical results.
The ¢lters were washed 3 times with 1UTBS with constant shaking at
room temperature. The secondary antibody was diluted in 3% BSA in
1UTBS and the ¢lter was incubated for 45 min at room temperature
with constant shaking. The ¢lters were washed as before. The antigen
was visualized using the ECL detection method as described by the
suppliers. Membrane protein and soluble protein were measured by
standard procedures [31]. Bovine serum albumin was used as a stand-
ard in all cases. Gel electrophoresis was carried out according to
standard procedures [32].
3. Results
3.1. Expression of beta subunits in adult rat brain as detected
by beta generic and beta isoform speci¢c antibodies
Prior to carrying out these studies to determine the pattern
of expression of beta subunits in di¡erentiating IMR32 cells
as detected by our beta generic antibody, Ab CW20, we
needed to compare the pattern of reactivity obtained with
Ab CW20 to a panel of antibodies speci¢c for the individual
beta isoforms [20,28]. As shown in Fig. 1, the Ab CW20 yields
a signal which can be discriminated into ‘high’ and ‘low’ mo-
lecular weight beta subunits. Using the antibodies speci¢c for
the L1b, L2, L3 and L4 isoforms, it is clear that the L1b and L2
isoforms (lanes 2 and 3) comprise the upper band of Ab
CW20 reactivity while the L3 and L4 (lanes 4 and 5) comprise
the lower band of antibody reactivity. It is of interest that the
L3 and L4 isoforms tended to migrate as narrow bands while
the mobility of the L1b and L2 isoforms was broad and dif-
fuse.
3.2. Increased expression of N-type K1B and L subunits in
di¡erentiating IMR32 cells
Ab CW14, an anti-peptide antibody which reacts with a 230
kDa protein present only in neuronal samples, and does not
cross-react with the L-type VDCC present in skeletal muscle,
was used to determine the expression level of K1B protein in
human IMR32 cells. Western blot analysis of di¡erentiating
IMR32 reveals a dramatic upregulation of K1B between day 8
and day 10 of treatment with cAMP analogs (Fig. 2A). This
dramatic upregulation of N-type K1B subunit protein parallels
the acquisition of [125I]CTX binding sites during di¡erentia-
tion as determined by Scatchard analysis (undi¡erentiated
IMR32 cells Kd = 10.5 pM with Bmax 3.5 þ 1.0 fmol/mg and
day 14 di¡erentiated IMR32 cells Kd = 17.5 pM with Bmax
17.5 þ 2 fmol/mg). The increase in K1B expression is even
more striking when compared to either the constitutive pat-
tern of expression of Na,K-ATPase K1 isoform (the lower
band in the immunoreactive doublet shown in Fig. 2B) or
the di¡erentiation-dependent increase in expression of the
K3 isoform (the upper band in the immunoreactive doublet
shown in Fig. 2B) [33].
Our attention then focused on the pattern of beta isoforms
expressed in di¡erentiating IMR32 cells (Fig. 3). Ab CW20
reacts with all recombinant beta subunit isoforms expressed in
HEK293 cells (data not shown) and evidences a pattern of
reactivity in rat forebrain which is a composite of the reac-
tivity obtained with beta isoform speci¢c antibodies (Fig. 1).
Using Ab CW20, we detected a single immunoreactive protein
of approximately 82 kDa in di¡erentiated IMR32 cells (Fig.
3). This apparent size is consistent with it being either the L1b
or L2 isoform (Fig. 1). In addition, there was a faint signal
which corresponded to a beta subunit of 55 kDa which could
be indicative of one of the smaller beta subunits such as the
L1c, L3 or L4 isoforms or perhaps a proteolytic remnant of
the L1b. There was a very good temporal correlation between
the intensity of the 82 kDa beta subunit and the appearance
of the K1B subunit.
3.3. The L1b subunit increases upon di¡erentiation of IMR32
cells
To identify the 82 kDa beta subunit which was observed to
greatly increase upon di¡erentiation of IMR32 cells and to
analyze the pattern of expression of beta subunits in develop-
ing rat brain, we used antibodies which speci¢cally recognize
the L1b, L2 and L3 isoforms. As shown in Fig. 4, the L1b
isoform was detected as the major beta isoform and was
shown to increase in representative samples of di¡erentiating
IMR32 cells. In addition to the 82 kDa L1b detected, there
was an unidenti¢ed protein with a higher apparent molecular
weight which was also detected by the anti-L1b antibody in all
IMR32 samples and the rat forebrain sample. The immuno-
staining of L1b and this unidenti¢ed protein was fully reversed
by excess peptide. This unidenti¢ed protein is currently under
investigation. There was a very faint signal obtained using
anti-L3 antibodies in the di¡erentiated IMR32 cell sample
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Fig. 2. Increased expression of N-type K1B subunit following di¡er-
entiation of IMR32 cells. IMR32 cells were di¡erentiated as de-
scribed in Section 2. Cells were harvested as described and resolved
on a 4^17% gradient gel, transferred to nitrocellulose and probed
with Ab CW14 (1/100 dilution, Panel A) or mAb 9A7 (1/10 000 di-
lution, Panel B). The samples are as follows: lane 1: day 0; lane 2:
day 2; lane 3: day 4; lane 4: day 6; lane 5: day 8; lane 6: day 10;
lane 7: day 12; lane 8: day 14; lane 9: day 16; lane 10: adult rat
forebrain. The protein concentration was 150 Wg/lane.
Fig. 3. A single beta subunit is predominantly expressed in di¡eren-
tiating IMR32 cells. IMR32 cells were di¡erentiated as described in
Section 2: Cells were harvested as described and resolved on a
4^17% gradient gel, transferred to nitrocellulose and probed with
Ab CW20 (1/200 dilution). The samples are as follows: lane 1:
adult rat forebrain; lane 2: day 0; lane 3: day 2; lane 4: day 4;
lane 5: day 6; lane 6: day 10; lane 7: day 12; lane 8: day 14; lane
9: day 16. The protein concentration was 150 Wg/lane. The position
of the authentic beta isoforms present in the rat brain samples are
indicated.
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(Fig. 4, lane 3). Interestingly, the anti-L3 antibody identi¢ed a
second protein with an apparent molecular weight of 82 kDa
in day 4 and day 10 di¡erentiated IMR32 cells. While the L2
isoform was not detected in IMR32 cells, adult rat brain was
positive for L2 expression. It can thus be concluded from these
experiments that the L1b is the predominant protein detected
by Ab CW20 in the di¡erentiated IMR32 cell samples.
Of additional note is the di¡erence in the mobility of the
L1b expressed in IMR32 cells compared to the L1b endoge-
nous to rat brain (Fig. 4, panel A). The beta subunit present
in IMR32 cells as detected by both the anti-L1b antibody
(Fig. 4) and the beta generic antibody Ab CW20 (Fig. 3) is
a discrete band as resolved by SDS-PAGE. In contrast, the
immunoreactive L1b protein in adult rat brain migrates
broadly (Figs. 3 and 4).
4. Discussion
The human neuroblastoma cell line IMR32 has recently
become an accepted cellular model for the acquisition of the
neuronal phenotype in culture [2]. IMR32 cells exhibit a vari-
ety of calcium channel activities (L-, N- and T-type) [22] sug-
gesting that this cell line harbors a multitude of calcium chan-
nel K1 subunit isoforms, which when assembled with beta
subunits, constitute the active channel complexes. The beta
subunit which comprises these assembled calcium channel
complexes remains undetermined.
The acquisition of active N-type VDCC as previously de-
scribed [22,34,35] coincide well with our results on the tempo-
ral expression of the K1B subunit during IMR32 cell di¡er-
entiation. It is interesting to point out that the level of K1B
reached a maximum level of expression at a time (day 10)
which coincides with maximal expression of N-type current
[22] and then, following a slight decrease observed on day
12, the level of K1B was maintained at a constant level (day
12^day 16). This is an interesting observation as previous
studies have suggested that changes in the level of N-type
VDCC throughout di¡erentiation re£ected changes in protein
turnover rates [34]. Similar e¡ects upon [125I]CTX-labeled
N-type VDCC stability were seen in SY5Y cells di¡erentiated
in the presence of retinoic acid [34].
The central issue we sought to address in this study was to
identify the beta subunit that is expressed in parallel with
K1B. Prior studies on the puri¢ed N-type channel complex
from adult rabbit brain ¢rst suggested an exclusive association
of the L3 isoform with the K1B [12]. However, it was subse-
quently shown that the N-type calcium channel can associate
with di¡erent beta subunits (L1b, L3, L4) [21]. In di¡erentiat-
ing PC12 cells, both the L2 and L3 isoforms were detected in
association with the K1B subunit, but their level of expression
did not change upon treatment with NGF [1]. Therefore, to
streamline our e¡orts to probe for beta subunit content in
IMR32 cells, it was critical to these studies to employ an
anti-beta antibody (Ab CW20) which could monitor all beta
subunits simultaneously.
The data presented in this study demonstrate the singular
expression of the L1b protein in di¡erentiating IMR32 cells.
Signi¢cantly, neither the L2 nor the L3 were detected in di¡er-
entiated IMR32 cells. The coordinate expression of the K1B
subunit with the L1b strongly suggests that the resident N-
type VDCC is comprised of the K1B and L1b. Our observa-
tion of dramatic increases in K1B and L1b protein expressed
during IMR32 cells di¡erentiation supports previous studies
which sought an explanation for the overall increase in cal-
cium channel expression measured by [125I]CTX radioligand
binding [34]. In contrast to the dramatic increase in expression
of the K1B and the L1b subunits demonstrated in this study,
previous reports have identi¢ed the K2 subunits in undi¡er-
entiated IMR32 cells [36]. Interestingly, in vitro expression
studies have demonstrated K2-N coexpression modulates the
binding a⁄nity of CTX when coexpressed with both K1B
and L1b message in human embryonic kidney cells
(HEK293 cells) [37]. Therefore, it is of interest to further in-
vestigate the time course of expression of the IMR32 cell K2
subunit in response to di¡erentiation.
The comparable level of total K1B and the L1b subunits
throughout di¡erentiation may therefore re£ect their coordi-
nate expression as well as their association. A mechanism for
the regulation of cell surface expression of N-type channels in
IMR32 cells might also be controlled through the level of beta
subunit expression as in the case of alpha/beta assembly found
for Na,K-ATPase [38]. The alteration in surface expression of
[125I]CTX receptors which occurred upon introducing anti-
sense L1b oligonucleotides into IMR32 cells [39] implicates
the L1b in regulating the density of surface N-type VDCC
and is consistent with the speci¢c increase in L1b expression
associated with N-type channel expression in our experiments.
The impact of this single population of L1b subunits upon the
subunit composition of the other VDCC requires further in-
vestigation.
Until recently, the heterogeneity in beta subunit isoforms
has prompted studies focused primarily upon determining
their role in calcium channel regulation and modulation.
However, another role for beta subunits has come to light
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Fig. 4. Detection of beta isoforms in di¡erentiating IMR32 cells. IMR32 cells were di¡erentiated as described in Section 2, resolved by PAGE
on 10% acrylamide gels and transferred to nitrocellulose. Adult rat forebrain was included as a positive control. Representative panels were
probed with the following beta isoform speci¢c antibodies: Panel A: anti-L1b (1 ug IgG/ml), Panel B: anti-L2 (1 Wg IgG/ml); and Panel C:
anti-L3 (1 Wg IgG/ml). The representative samples are as follows: lane 1: di¡erentiated IMR32 cells (day 4); lane 2: di¡erentiated IMR32 cells
(day 10); lane 3: di¡erentiated IMR32 cells (day 14); lane 4: adult rat forebrain. The protein concentration was 150 Wg/lane.
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from studies in which the expression of beta has been elimi-
nated by either anti-sense competition [40] or genomic ‘knock-
outs’ [41]. Inhibition of beta subunit synthesis by knocking
out endogenous beta subunits expression in X. laevis oocytes
prevented both channel formation and K1E expression [40]. It
was speculated that at low levels of beta subunit expression
provided by the oocyte allowed for a beta subunit ‘chaperone’
e¡ect for the transport of the K1 to the cell surface while
higher levels of beta subunit expression were required for a
mature K1E-beta subunit complex. In case of the genomic
‘knock-out’ of the beta subunit in skeletal muscle, the absence
of the beta subunit lead to the absence of K1s expression,
disorganization of the T-tubule membrane and decreased
L-type current [41]. In contrast, in dysgenic mice which do
not express K1s, the beta subunit is transported to the mem-
brane [41]. Similarly, there is a requirement for K1s and beta
subunit interaction for the localization of the DHP receptor to
the plasma membrane of transfected non-muscle cells [42].
Thus, the di¡erentiation-dependent expression of the L1b sub-
unit in IMR32 cells may re£ect an increased demand for spe-
ci¢c proteins which function in the tra⁄cking of VDCC sub-
units through the cell. In conclusion, it is interesting to
speculate that the unitary expression of the L1b subunit in
IMR32 cells may re£ect a role for this protein which extends
beyond its role as a component of a mature VDCC channel.
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